RVT-1401

· Immunovant Sciences GmbH

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for RVT-1401, covering 2022-01-24 to 2023-12-20. Get the full timeline:

Most recent: Clinical Trial Update: A Study of RVT-1401 in Myasthenia Gravis (MG) Patients [Phase 2]